The QuantWave forecast for REGN regeneron pharmaceuticals, inc.
The graph shows the results of our forecasting system for REGN. You can view historical price data with markers indicating where our system has signaled and where projected targets have been achieved. This demonstrates how our system's forecasts have performed in real market conditions.
We do not display all achieved goals on the graph; detailed information is available in the corresponding section on this page.
The graph is interactive. Hover over target icons to see when the forecast was created.
Access the REGN Forecast
REGN Achieves Targets with Precision, as Predicted by QuantWave
Show news about the achieved forecast.
| Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
|---|---|---|---|---|---|
| 2022-07-01 | 592.86 $ | 2025-05-30 | 489.54 $ | 17.43% | |
| 2022-08-04 | 612.34 $ | 2022-10-13 | 749.35 $ | 22.38% | |
| 2024-04-16 | 890.32 $ | 2024-06-14 | 1032.1 $ | 15.92% | |
| 2024-05-07 | 965.83 $ | 2024-08-13 | 1153.39 $ | 19.42% | |
| 2024-05-14 | 980.44 $ | 2024-08-15 | 1170.31 $ | 19.37% | |
| 2024-05-21 | 989.71 $ | 2024-08-15 | 1170.31 $ | 18.25% | |
| 2024-05-28 | 969.01 $ | 2024-08-13 | 1153.39 $ | 19.03% | |
| 2024-06-11 | 1006.23 $ | 2024-08-13 | 1153.39 $ | 14.62% | |
| 2024-07-02 | 1040.2 $ | 2024-08-19 | 1191.77 $ | 14.57% | |
| 2024-10-08 | 1000.97 $ | 2024-10-31 | 834.62 $ | 16.62% | |
| 2024-10-15 | 1012.19 $ | 2024-10-31 | 834.62 $ | 17.54% | |
| 2024-12-13 | 728.18 $ | 2025-06-05 | 482.34 $ | 33.76% | |
| 2024-12-31 | 709.29 $ | 2025-06-05 | 482.34 $ | 32% | |
| 2025-01-14 | 687.92 $ | 2025-04-04 | 571.74 $ | 16.89% | |
| 2025-01-21 | 684.86 $ | 2025-04-04 | 571.74 $ | 16.52% | |
| 2025-01-23 | 691.67 $ | 2025-04-04 | 571.74 $ | 17.34% | |
| 2025-01-28 | 683.4 $ | 2025-04-04 | 571.74 $ | 16.34% | |
| 2025-02-04 | 694.07 $ | 2025-04-04 | 571.74 $ | 17.63% | |
| 2025-02-11 | 662.62 $ | 2025-04-10 | 544.76 $ | 17.79% | |
| 2025-02-18 | 677.1 $ | 2025-04-04 | 571.74 $ | 15.56% | |
| 2025-02-20 | 693.94 $ | 2025-04-08 | 555.15 $ | 20% | |
| 2025-02-21 | 698.24 $ | 2025-04-08 | 555.15 $ | 20.49% | |
| 2025-02-25 | 721.31 $ | 2025-04-08 | 555.15 $ | 23.04% | |
| 2025-02-26 | 704.83 $ | 2025-05-09 | 526.2 $ | 25.34% | |
| 2025-02-27 | 700.68 $ | 2025-05-09 | 526.2 $ | 24.9% | |
| 2025-02-28 | 696.65 $ | 2025-05-09 | 526.2 $ | 24.47% | |
| 2025-02-28 | 696.65 $ | 2025-05-30 | 489.54 $ | 29.73% | |
| 2025-03-04 | 673.47 $ | 2025-05-30 | 489.54 $ | 27.31% | |
| 2025-03-07 | 705.4 $ | 2025-05-30 | 489.54 $ | 30.6% | |
| 2025-03-10 | 742.6 $ | 2025-05-30 | 489.54 $ | 34.08% | |
| 2025-03-14 | 664.88 $ | 2025-06-04 | 484.19 $ | 27.18% | |
| 2025-03-21 | 656.51 $ | 2025-06-04 | 484.19 $ | 26.25% | |
| 2025-03-21 | 656.51 $ | 2025-06-04 | 484.19 $ | 26.25% | |
| 2025-04-01 | 615.16 $ | 2025-05-30 | 489.54 $ | 20.42% | |
| 2025-04-02 | 623.73 $ | 2025-05-30 | 489.54 $ | 21.51% | |
| 2025-04-04 | 571.74 $ | 2025-05-30 | 489.54 $ | 14.38% |
How will the cost change for regeneron pharmaceuticals, inc. (REGN)
By purchasing our forecast for REGENERON PHARMACEUTICALS, INC. (REGN), you can gain valuable insights into the changes in the cost of the stock during the period from December 2024 to April 2025. Our forecast will provide you with information on whether the cost of REGN will rise or fall during this time frame, allowing you to make informed investment decisions.
Knowing the future value and dynamics of REGN can be highly beneficial for earning and diversifying your portfolio. With this information, you can strategically plan your investments and take advantage of potential price movements. Whether you choose to buy or sell REGN stocks, our forecast will help you make the right decision to maximize your profits.
Stay updated with the release of new forecasts for REGN on our website to stay informed about the entire investment period. With our accurate predictions, you can confidently navigate the market and make informed investment choices. Don't miss out on the opportunity to enhance your portfolio with our reliable forecast for REGENERON PHARMACEUTICALS, INC. (REGN).
The latest news about regeneron pharmaceuticals, inc.
October 31, 2025Regeneron Pharmaceuticals Inc. REGN Receives Positive Opinion from European Medicines Agency ~1 min.Regeneron Pharmaceuticals Inc. (REGN) recently received a positive opinion from the European Medicines Agency for its drug Libtayo....
September 5, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance ~1 min.Regeneron Pharmaceuticals Inc. (REGN) has been making waves in the stock market recently, with Evercore ISI maintaining a buy rating and a price target of 750....
July 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals ~1 min.Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....
June 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target ~1 min.Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....
June 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin ~1 min.QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....
June 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit ~1 min.REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....
June 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit ~2 min.REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....
June 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25% ~1 min.REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....
June 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction ~2 min.REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....
June 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit ~1 min.REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....
Other QuantWave offers:
REGN
REGENERON PHARMACEUTICALS, INC.
Healthcare
MAR
MARRIOTT INTERNATIONAL, INC.
Consumer Discretionary
PSX
PHILLIPS 66
Energy
ABT
ABBOTT LABORATORIES
Healthcare
TMUS
T-MOBILE US, INC.
Telecommunications
TM
TOYOTA MOTOR CORPORATION
Automotive